Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease

Neuroscience Letters

Volumn 408, Issue 1, 2006, Pages 68-72

  Raygani, Asad Vaisi ^a,b   Rahimi, Zohreh ^a,c   Kharazi, Hadi ^a   Tavilani, Haidar ^d   Pourmotabbed, Tayebeh ^e  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Alzheimer's disease (AD); Apolipoprotein (a) Lp(a); Apolipoprotein A1 (apoA1); Apolipoprotein B (apoB); Apolipoprotein E (APOE); HDL C; LDL C

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; IRAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; IRAN; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33749066121     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.08.048     Document Type: Article

References (48)

1. Abdollahi M.R., Guthrie P.A.I., Smith G.D., Lawlor D.A., Ebrahim S., and Day I.N.M. Integrated single-label liquid-phase assay of APOE codons 112 and 158 and a lipoprotein study in British women. Clin. Chem. 52 (2006) 1420-1423
2. Boer J.M.A., Feskens E.J.M., Schouten E.G., Havekes L.M., Seidell J.C., and Kromhout D. Lipid profiles reflecting high and low risk for coronary heart disease: contribution of apolipoprotein E polymorphism and lifestyle. Atherosclerosis 136 (1998) 395-402
3. Bonarek M., Barberger-Gateau P., Letenneur L., Deschamps V., Iron A., Dubroca B., and Dartigues J.F. Relationships between cholesterol, apoli-poprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID Study. Neuroepidemiology 19 (2000) 141-148
4. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weis-Graber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., and Ignatius M.J. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83 (1989) 1015-1031
5. Chen Y.J., Cheng S., Ye W., Ge B., Liu Z., and Zhang Y. Serum apolipoprotein A I, B100 and E levels and apolipoprotein E polymorphism in patients with Alzheimer's disease and multiple infarction dementia in Chinese population. Hua Xi Yi Ke Da Xue Xue Bao 32 (2001) 389-391
6. Compton D., Wavrant DeVrieze F., Petersen R.C., Tangalos E., Li L., and Hardy J. Possible association between genetic variability at the apolipoprotein(a) locus and Alzheimer's disease in apolipoprotein E2 carriers. Neurosci. Lett. 331 (2002) 60-62
7. Corder E.H., Sanders W.J., Strittmatter D.E., Schmechel P.C., Gaskell P.C., Small G.W., and Roses A.D. Gene dose of APOE E type 4 allele and risk of AD in late onset families. Science 61 2 (1993) 921
8. de-Andrade F.M., Larrandaburu M., Callegari-Jacques S.M., Gastaldo G., and Hutz M.H. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz. J. Med. Biol. Res. 33 (2000) 529-537
9. Ehnholm C., Lukka M., Kuusi T., Nikkila E., and Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. Lipid Res. 27 (1986) 227-235
10. Emanuele E., Peros E., Tomaino C., Feudatari E., Bernardi L., Binetti G., Maletta R., D'Angelo A., Montagna L., Bruni A.C., and Geroldi D. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci. Lett. 357 1 (2004) 45-48
11. Eto M., Watanabe K., and Ishii K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin. Genet. 30 (1986) 422-427
12. Evans A.E., Zhang W., and Moreel J.F. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum. Genet. 92 (1993) 191-197
13. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-Mental state, a practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 12 (1975) 189-198
14. Gerdes L.L., Klausen I.C., Sihm L., and Faergeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 9 (1992) 155-167
15. Golabek A., Marques M.A., Lalowski M., and Wisniewski T. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci. Lett. 191 (1995) 79-82
16. Hall K., Murrell J., Ogunniyi A., Deeg M., Baiyewu O., Gao S., Gureje O., Dickens J., Evans R., Smith-Gamble V., Unverzagt F.W., Shen J., Hendrie H., and Cholesterol. APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 66 (2006) 223-227
17. Hallman D.M., Boerwinkle E., Saha N., Sandholzer C., Menzel H.J., Csázár A., and Utermann G. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49 (1991) 338-349
18. Hoshino T., Kamino K., and Matsumoto M. Gene dose affect of the APOE4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease. Neurobiol. Aging 23 (2002) 41-45
19. Isbir T., Agachan B., Yilmaz H., Aydin M., Kara I., Eker E., and Eker D. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 16 2 (2001) 77-81
20. Johan S.W.M., Weitzner G., and Rozen R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19 (1991) 408
21. Katzman R., Zhang M.J., and Chen P.J. Effects of apolipoprotein E on dementia and aging in the shanghai surrey of Dementia. Neurology 49 (1997) 779-785
22. Kawano M., Kawakami M., Otsuka M., Yashima H., Yaginuma T., and Ueki A. Marked decrease of plasma apolipoprotein AI and AII in Japanese. Clin. Chim. Acta 239 (1995) 209-211
23. Khachaturian A.S., Corcoran C.D., Mayer L.S., Zandi P.P., Breitner J.C., and Cache County Study Investigators. Apolipoprotein E epsilon 4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch. Gen. Psychiatry 61 5 (2004) 518-524
24. Kuriyama M., Takahashi K., Yamano T., Hokezu Y., Togo S., Osame M., and Igakura T. Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn. J. Psychiatry Neurol. 48 (1994) 589-593
25. Liu H.C., Hong C.Y., Wang S.Y., Wang S.J., Fuh J.L., Wang P.N., Shyn H.Y., and Teng E.L. APOE genotype in relation to AD and cholesterol. Neurology 53 (1999) 962-968
26. Lopez O.L., Pouse S.L., Kamboh M.L., Androer R., Gallego M.L., Becker J.T., and DeKosky S.T. Apolipoprotein E polymorphism in Alzheimer's Disease: a comparative study of two search populations from Spain and the USA. Eur. Neurol. 39 (1998) 229-233
27. Luoma P.V. Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. Pharmacol. Toxicol. 81 (1997) 57-64
28. Mahley R.W., and Rall S.C. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
29. Mckhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of NINCDS-DRDA work group under the auspices of the Department of Health and Human Services task force of Alzheimer's disease. Neurology 34 (1984) 939-944
30. Merched A., Xia Y., Papadopoulou A., Siest G., and Visvikis S. Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci. Lett. 242 2 (1998) 117-119
31. Merched A., Xiaa Y., Visvikisa S., Serotb J.M., and Siesta G. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol. Aging 21 (2000) 27-30
32. Pritchard A., Harris J., Pritchard C.W., St Clair D., Lemmon H., Lambert J.C., Chartier-Harlin M.C., Hayes A., Thaker U., Iwatsubo T., Mann D.M., and Lendon C. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease. Neurosci. Lett. 382 (2005) 221-226
33. Raygani A.V., Zahrai M., Raygani A.V., Doosti M., Javadi E., Rezaei M., and Pourmotabbed T. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran. Iran. Neurosci Lett. 375 (2005) 1-6
34. Romas S.N., Tang M.X., Berglund L., and Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 54 (2000) 2356-2358
35. Rosenson R.S. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess. Arch. Intern. Med. 156 (1996) 1278-1284
36. Rubinsztein D.C. Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair as a risk for Alzheimer's disease. Psychol Med 25 (1995) 223-229
37. Saunders A.M., Strittmatter W.J., Schmeched D., George-Hylop P.H., Perickak-Vance M.A., Joo S.H., and Rosi B.J. Association of Apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 467-472
38. Scacchi R., De Bernardini L., Mantuano E., Vilardo T., Donini L.M., Ruggeri M., Gemma A.T., Pascone R., and Corbo R.M. DNA polymerase of apolipoprotein B, and angiotensin 1-converting enzyme gene, and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 9 (1998) 186-190
39. Solfrizzi V., Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., and Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's Disease. J. Neurol. Neurosurg. Psychiatry 72 (2002) 732-736
40. Song H., Saito K., Seishima M., Noma A., Urakami K., and Nakashima K. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease. Neurosci. Lett. 231 (1997) 175-178
41. Srinivasan S.R., Ehnholm C., Wendy Wattigney A., and Berenson S.G. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study. Atherosclerosis 127 (1996) 73-79
42. Taddei K., Clarnette R., Gandy S.E., and Martins R.N. Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci. Lett. 223 (1997) 29-32
43. Uterman G., Hese M., and Steinmetz A. Apolipoprotein E polymorphism and occurrence of dysbetalipoproteinemia in man. Nature 260 (1997) 604-607
44. Valveny N., Esteban E., Kandi L.M., and Moral P. APO E Polymorphism in Spanish and Moroccan populations. Clin. Genet. 51 (1997) 354-356
45. van Bockxmeer F.M., and Kakulas B.A. Apolipoprotein E and Alzheimer's disease. Nature 373 6514 (1995) 285
46. Venkatramane P., Chengal R., and Ferrell R.E. Apolipoprotein E polymorphism among the Indian populations and its comparison with other Asian populations. IJHG 1 2 (2001) 123-128
47. Wehr H., Parnowski T., Puzynski S., Bednarska-Makaruk M., Bisko M., Kotapka-Minc S., Rodo M., and Wolkowska M. Apolipoprotein E genotype, and lipid, and lipoprotein levels in dementia. Dement. Geriatr. Cogn. Disord. 11 (2000) 70-73
48. Wenham P.R., Price W.H., and Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 337 (1991) 1158-1159